Biocept Stock

Biocept Gross Profit

Gross Profit of Biocept (BIOCQ) as of Mar 3, 2026.

Gross Profit

0USD

Last updated: Mar 3, 2026

Gross Profit of Biocept is 2026 0 USD. Gross Profit of Biocept was 2025 0 USD. It decreases by % lower compared to the previous year.

The Biocept Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

GROSS MARGIN (%)
Date
GROSS MARGIN (%)
Jan 1, 2011
0 base
Jan 1, 2012
-99,091 base
Jan 1, 2013
-169,231 base
Jan 1, 2014
-156,923 base
Jan 1, 2015
-65,410 base
Jan 1, 2016
-11,491 base
Jan 1, 2017
-8,442 base
Jan 1, 2018
-20,923 base
Jan 1, 2019
-9,855 base
Jan 1, 2020
2,229 base
Jan 1, 2021
3,835 base
Jan 1, 2022
-998 base
Invalid Date
-10,118 base
Invalid Date
-3,870 base
Invalid Date
-1,166 base
YEARGROSS MARGIN (%)
2025 est -11,66
2024 est -38,70
2023 est -101,18
2022 -9,98
2021 38,35
2020 22,29
2019 -98,55
2018 -209,23
2017 -84,42
2016 -114,91
2015 -654,10
2014 -1569,23
2013 -1692,31
2012 -990,91
2011 -

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

Biocept Revenue

Biocept Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2011
0 USD
-12.27 M USD
-13.63 M USD
Jan 1, 2012
110,000 USD
-10.5 M USD
-12.26 M USD
Jan 1, 2013
130,000 USD
-7.94 M USD
-9.23 M USD
Jan 1, 2014
130,000 USD
-13.87 M USD
-15.87 M USD
Jan 1, 2015
610,000 USD
-16.41 M USD
-16.95 M USD
Jan 1, 2016
3.22 M USD
-18.03 M USD
-18.4 M USD
Jan 1, 2017
5.07 M USD
-21.17 M USD
-21.61 M USD
Jan 1, 2018
3.25 M USD
-24.26 M USD
-25.21 M USD
Jan 1, 2019
5.53 M USD
-23.06 M USD
-25.26 M USD
Jan 1, 2020
27.46 M USD
-15.47 M USD
-17.81 M USD
Jan 1, 2021
61.25 M USD
-2.41 M USD
-2.82 M USD
Jan 1, 2022
25.86 M USD
-31.98 M USD
-32.09 M USD
Invalid Date
2.55 M USD
-24.68 M USD
-3.26 M USD
Invalid Date
6.67 M USD
-23.76 M USD
-810,197.95 USD
Invalid Date
22.12 M USD
-17.44 M USD
-499,035 USD

Biocept Margins

Biocept stock margins

The Biocept margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biocept. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biocept.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2011
-9.98 %
0 %
0 %
Jan 1, 2012
-990.91 %
-9,545.45 %
-11,145.46 %
Jan 1, 2013
-1,692.31 %
-6,107.69 %
-7,100 %
Jan 1, 2014
-1,569.23 %
-10,669.23 %
-12,207.69 %
Jan 1, 2015
-654.1 %
-2,690.16 %
-2,778.69 %
Jan 1, 2016
-114.91 %
-559.94 %
-571.43 %
Jan 1, 2017
-84.42 %
-417.55 %
-426.23 %
Jan 1, 2018
-209.23 %
-746.46 %
-775.69 %
Jan 1, 2019
-98.55 %
-417 %
-456.78 %
Jan 1, 2020
22.29 %
-56.34 %
-64.86 %
Jan 1, 2021
38.35 %
-3.93 %
-4.6 %
Jan 1, 2022
-9.98 %
-123.67 %
-124.09 %
Invalid Date
-9.98 %
-967.76 %
-127.78 %
Invalid Date
-9.98 %
-356.37 %
-12.15 %
Invalid Date
-9.98 %
-78.84 %
-2.26 %

Biocept Stock analysis

What does Biocept do? Biocept is one of the most popular companies on Eulerpool.com.

Frequently Asked Questions about Biocept stock

On Eulerpool you can find the complete historical development of Gross Profit Biocept since 2006 – with annual values, charts, and detailed analysis.

Income Statement — Biocept

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — Biocept